Insider transactions

EDGAR

KAIROS PHARMA, LTD.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-15.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

This issuer has insider filings in the store, but no transaction in this window or code group.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.

Showing 1–5 of 5

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
JANE STREET GROUP, LLC Partly reported under another manager13,595 SH22,296 dollarsLower by 20,154 Prior quarter: 33,749Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 9,707 SH15,919 dollarsLower by 222,171 Prior quarter: 231,878Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 6,869 SH11,265 dollarsLower by 57,015 Prior quarter: 63,884Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Nuveen, LLC Partly reported under another manager2,517 SH4,178 dollarsNot in the prior quarter’s filings read Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
UBS Group AG Partly reported under another manager1,033 SH1,694 dollarsLower by 5,228 Prior quarter: 6,261Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • CITADEL ADVISORS LLC 309,834 SH
  • Virtu Financial LLC 82,092 SH
  • GEODE CAPITAL MANAGEMENT, LLC 78,924 SH
  • SevenBridge Financial Group, LLC 44,286 SH
  • Aptus Capital Advisors, LLC 44,286 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 29,292 SH
  • STATE STREET CORP 24,100 SH
  • XTX Topco Ltd 14,918 SH
  • Tower Research Capital LLC (TRC) 3,733 SH
  • BARCLAYS PLC 723 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Armistice Capital, LLC Common Stock, par value $0.001 per share4.99884,938.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-25-003587 Dispute this row
Steven Boyd Common Stock, par value $0.001 per share4.99884,938.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-25-003587 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,024,280 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024117,969
2025235,520
2026254,026

Filings made before the SEC required XML are listed, not extracted.

Back to KAIROS PHARMA, LTD.